Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Feb-09 4:29 PM View:  | Barker Sam L Director | Atherogenics Inc. (AGIX) | 04-Feb-09 | Sale | 6,000 | $0.04 | $210.00 | (23%) 26.0K to 20.0K | (43%) |
| 05-Feb-09 4:29 PM View: | Barker Sam L Director | Atherogenics Inc. (AGIX) | 04-Feb-09 | Sale | 20,000 | $0.04 | $720.00 | (100%) 20.0K to 0 | (39%) |
| 04-Nov-08 9:29 AM View: | Henos Michael A Director | Atherogenics Inc. (AGIX) | 31-Oct-08 | Market Sale | 100,000 | $0.06 | $5,900.00 | (100%) 100.0K to 0 | 13% |
| 05-Feb-09 10:00 PM View: | Colonnese Mark P VP Commercial Operations & CFO | Atherogenics Inc. (AGIX) | 25-Sep-08 | Gift | 25,000 | -- | -- | (100%) 25.0K to 0 | |
| 11-Feb-08 3:09 PM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 08-Feb-08 | Market Purchase | 50,000 | $0.64 | $32,000.00 | 163% 30.75K to 80.75K | 28% |
| 01-Feb-08 11:00 AM View: | Barker Sam L Director | Atherogenics Inc. (AGIX) | 25-Jan-08 | Market Purchase | 20,000 | $0.39 | $7,800.00 | 333% 6.0K to 26.0K | 110% |
| 01-Feb-08 11:00 AM View: | Barker Sam L Director | Atherogenics Inc. (AGIX) | 25-Jan-08 | Market Purchase | 5,000 | $0.39 | $1,950.00 | 500% 1.0K to 6.0K | 110% |
| 15-Feb-08 9:11 AM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 22-Jan-08 | Market Sale | 3,386 | $0.39 | $1,320.54 | (4%) 80.75K to 77.37K | (110%) |
| 31-Dec-07 10:26 AM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 28-Dec-07 | Market Sale | 24,733 | $0.38 | $9,465.23 | (45%) 55.48K to 30.75K | (114%) |
| 31-Dec-07 10:26 AM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 27-Dec-07 | Market Sale | 48,732 | $0.40 | $19,492.80 | (47%) 104.22K to 55.48K | (105%) |
| 31-Dec-07 10:26 AM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 26-Dec-07 | Market Sale | 2,440 | $0.40 | $976.00 | (2%) 106.66K to 104.22K | (105%) |
| 26-Dec-07 12:02 PM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 20-Dec-07 | Market Sale | 7,657 | $0.43 | $3,292.51 | (7%) 114.31K to 106.66K | (91%) |
| 07-Dec-07 4:25 PM View: | Henos Michael A Director | Atherogenics Inc. (AGIX) | 06-Dec-07 | Market Sale | 30,000 | $0.48 | $14,539.40 | (23%) 130.0K to 100.0K | (69%) |
| 29-Nov-07 5:06 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 28-Nov-07 | Market Sale | 1,679,950 | $0.50 | $839,964.00 | (18%) 9.15M to 7.47M | (64%) |
| 29-Nov-07 5:06 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 27-Nov-07 | Market Sale | 283,041 | $0.64 | $181,946.00 | (3%) 9.44M to 9.15M | (27%) |
| 05-Sep-07 4:03 PM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 29-Aug-07 | Market Sale | 55,518 | $2.15 | $119,364.00 | (33%) 169.83K to 114.31K | 62% |
| 01-Aug-07 4:54 PM View: | Medford Russell M President & CEO Director | Atherogenics Inc. (AGIX) | 01-Aug-07 | Option Exercise | 10,000 | $0.30 | $3,000.00 | 2% 487.14K to 497.14K | |
| 06-Jun-07 11:39 AM View: | Medford Russell M President & CEO Director | Atherogenics Inc. (AGIX) | 05-Jun-07 | Option Exercise | 10,000 | $0.30 | $3,000.00 | 2% 477.14K to 487.14K | |
| 02-Apr-07 4:38 PM View: | Scott Robert A Exec VP Research & Development | Atherogenics Inc. (AGIX) | 02-Apr-07 | Market Purchase | 36,000 | $2.77 | $99,576.00 | 253% 14.2K to 50.2K | (70%) |
| 21-Mar-07 9:13 AM View: | Colonnese Mark P Exec VP, Commercial Operations | Atherogenics Inc. (AGIX) | 20-Mar-07 | Option Exercise | 25,000 | $0.38 | $9,500.00 | 100% 0 to 25.0K | |
| 22-Jan-07 1:38 PM View: | Dagi Tao F Director | Atherogenics Inc. (AGIX) | 19-Jan-07 | Option Exercise | 12,000 | $0.38 | $4,560.00 | 46% 26.34K to 38.34K | |
| 05-Sep-06 9:24 AM View: | Barker Samuel L Director | Atherogenics Inc. (AGIX) | 31-Aug-06 | Market Purchase | 1,000 | $14.11 | $14,109.00 | 100% 0 to 1.0K | (94%) |
| 03-Jul-06 2:53 PM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 30-Jun-06 | Market Purchase | 17,132 | $13.06 | $223,794.00 | 11% 152.7K to 169.83K | (94%) |
| 03-Jul-06 2:53 PM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 29-Jun-06 | Market Purchase | 22,868 | $12.97 | $296,660.00 | 18% 129.83K to 152.7K | (94%) |
| 15-Jun-06 10:00 PM View: | Scott Robert A Exec VP Research & Development | Atherogenics Inc. (AGIX) | 13-Jun-06 | Option Exercise | 14,204 | $7.04 | $99,996.20 | 100% 0 to 14.2K | |
| 31-May-06 3:55 PM View: | Bryson Vaughn D Director | Atherogenics Inc. (AGIX) | 30-May-06 | Market Purchase | 20,000 | $13.87 | $277,474.00 | 18% 109.83K to 129.83K | (94%) |
| 25-May-06 6:22 PM View: | Pappas Arthur M Director | Atherogenics Inc. (AGIX) | 24-May-06 | Market Purchase | 1,000 | $12.97 | $12,969.00 | 7% 14.0K to 15.0K | (94%) |
| 24-May-06 10:14 AM View: | Pappas Arthur M Director | Atherogenics Inc. (AGIX) | 22-May-06 | Market Purchase | 3,000 | $13.52 | $40,569.30 | 27% 11.0K to 14.0K | (94%) |
| 01-May-06 10:03 AM View: | Pappas Arthur M Director | Atherogenics Inc. (AGIX) | 27-Apr-06 | Market Purchase | 3,000 | $14.03 | $42,092.10 | 38% 8.0K to 11.0K | (94%) |
| 01-May-06 10:43 AM View: | Bearman David Director | Atherogenics Inc. (AGIX) | 27-Apr-06 | Option Exercise | 45,600 | $8.17 | $372,440.00 | 100% 0 to 45.6K | |
| 13-Apr-06 3:46 PM View: | Medford Russell M President & CEO Director | Atherogenics Inc. (AGIX) | 12-Apr-06 | Option Exercise | 2,500 | $0.30 | $750.00 | < 1% 474.64K to 477.14K | |
| 27-Mar-06 4:28 PM View: | Pappas Arthur M Director | Atherogenics Inc. (AGIX) | 24-Mar-06 | Market Purchase | 1,000 | $15.83 | $15,827.00 | 14% 7.0K to 8.0K | (95%) |
| 20-Mar-06 4:16 PM View: | Scott William A Director | Atherogenics Inc. (AGIX) | 16-Mar-06 | Market Sale | 41,800 | $15.31 | $640,077.00 | (100%) 41.8K to 0 | 95% |
| 01-Feb-06 6:45 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 01-Feb-06 | Market Purchase | 225,000 | $17.23 | $3,876,750.00 | 5% 4.54M to 4.77M | (95%) |
| 01-Feb-06 6:45 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 31-Jan-06 | Market Purchase | 250,000 | $16.94 | $4,235,000.00 | 6% 4.29M to 4.54M | (95%) |
| 01-Feb-06 6:45 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 30-Jan-06 | Market Purchase | 125,000 | $16.86 | $2,107,500.00 | 3% 4.17M to 4.29M | (95%) |
| 29-Dec-05 1:20 PM View: | Scott Robert A Sr VP Clinical Dev & RA | Atherogenics Inc. (AGIX) | 28-Dec-05 | Market Sale | 3,900 | $20.01 | $78,025.70 | (100%) 3.9K to 0 | 96% |
| 29-Dec-05 12:12 PM View: | Medford Russell M President & CEO Director | Atherogenics Inc. (AGIX) | 28-Dec-05 | Market Sale | 150,000 | $20.02 | $3,003,000.00 | (24%) 624.64K to 474.64K | 96% |
| 29-Dec-05 1:20 PM View: | Scott Robert A Sr VP Clinical Dev & RA | Atherogenics Inc. (AGIX) | 28-Dec-05 | Option Exercise | 16,100 | $7.04 | $113,344.00 | 413% 3.9K to 20.0K | |
| 29-Dec-05 1:20 PM View: | Scott Robert A Sr VP Clinical Dev & RA | Atherogenics Inc. (AGIX) | 28-Dec-05 | Market Option Sale | 16,100 | $20.01 | $322,106.00 | (81%) 20.0K to 3.9K | 96% |
| 29-Dec-05 12:01 PM View: | Alexander R Wayne Director | Atherogenics Inc. (AGIX) | 28-Dec-05 | Market Sale | 25,000 | $20.09 | $502,135.00 | (5%) 460.9K to 435.9K | 96% |
| 29-Dec-05 12:57 PM View: | Colonnese Mark P Sr VP Finance & Admin & CFO | Atherogenics Inc. (AGIX) | 27-Dec-05 | Market Option Sale | 100,000 | $21.35 | $2,135,000.00 | (100%) 100.0K to 0 | 96% |
| 29-Dec-05 12:57 PM View: | Colonnese Mark P Sr VP Finance & Admin & CFO | Atherogenics Inc. (AGIX) | 27-Dec-05 | Option Exercise | 100,000 | $0.33 | $32,552.00 | 100% 0 to 100.0K | |
| 31-Oct-05 5:49 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 27-Oct-05 | Market Purchase | 30,000 | $15.27 | $458,100.00 | < 1% 4.14M to 4.17M | (95%) |
| 26-Oct-05 4:10 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 24-Oct-05 | Market Purchase | 50,000 | $15.30 | $765,000.00 | 1% 4.09M to 4.14M | (95%) |
| 24-Oct-05 4:18 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 21-Oct-05 | Market Purchase | 40,000 | $15.16 | $606,400.00 | < 1% 4.05M to 4.09M | (95%) |
| 24-Oct-05 4:18 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 20-Oct-05 | Market Purchase | 40,000 | $15.55 | $622,000.00 | < 1% 4.01M to 4.05M | (95%) |
| 18-Oct-05 4:08 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 17-Oct-05 | Market Purchase | 40,000 | $15.93 | $637,200.00 | 1% 3.97M to 4.01M | (95%) |
| 18-Oct-05 4:08 PM View: | Atticus Capital LLC 10% Owner | Atherogenics Inc. (AGIX) | 14-Oct-05 | Market Purchase | 50,000 | $15.97 | $798,500.00 | 1% 3.92M to 3.97M | (95%) |
| 11-Aug-05 9:11 AM View: | Alexander R Wayne Director | Atherogenics Inc. (AGIX) | 09-Aug-05 | Option Exercise | 25,000 | $0.10 | $2,500.00 | 6% 435.9K to 460.9K |
